Denis Chem Lab Ltd (BSE: 537536) is a Ahmedabad, Gujarat-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹86 Cr, it ranks #3,401 by market cap among the 6,137 Indian listed companies on FinBizNet, and #17 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹62.69 (as of 25 Oct 2026), the share price is 33.7% below its 52-week high of ₹94.60 and 11.7% above its 52-week low of ₹56.10. The share price is down 35.2% over one year and down 14.0% over three months.
| Current Price | ₹62.69 |
|---|---|
| Market Cap | ₹86 Cr |
| BSE Code | 537536 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Manufacturing Services |
| 52-Week Range | ₹56.10 – ₹94.60 |
| 1-Year Price Change | -35.2% |
| 3-Month Price Change | -14.0% |
| Beta (1Y) | 0.9 |
| Dividend Yield | 3.99% |
| Headquarters | Ahmedabad, Gujarat |
| Website | denischemlab.com |
| Revenue | ₹44 Cr |
|---|---|
| Net Profit | ₹2 Cr |
| Net Margin | 4.7% |
| EPS (Basic) | ₹1.47 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Denis Chem Lab Limited, a pharmaceutical company, engages in the manufacturing and marketing of sterile intravenous injectable products for human and veterinary use in India. The company’s products include antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti-anaerobic injections, anti-pyretic injections, irrigation and dialysis solutions, etc. It also provides contract manufacturing services for third parties, as well as manufactures and sells transfusion solutions in bottles. The company serves government and semi-government institutions, hospitals and nursing homes, aided agencies, and defense sector. It also exports its products to Sri Lanka, Vietnam, Cambodia, Somalia, Nepal, Ivory Coast, etc. The company was incorporated in 1980 and is based in Ahmedabad, India.
1. 0-0
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Torrent Pharma Ltd. | ₹1,73,448 Cr | 71.2 | 16.98% | ₹4,979 Cr | +28.0% |
| Aether Industries Limited | ₹20,419 Cr | 92.1 | 9.81% | ₹327 Cr | +88.8% |
| Alivus Life Sciences Ltd | ₹16,073 Cr | 27.7 | 18.36% | ₹640 Cr | +33.8% |
| Aarti Pharmalabs Ltd | ₹7,922 Cr | 43.2 | 8.49% | ₹536 Cr | -4.1% |
| Solara Active Pharma Sciences Limited | ₹3,361 Cr | -382.6 | -0.63% | ₹417 Cr | +3.3% |
| Sai Parenteral's Limited | ₹2,153 Cr | 110.9 | 2.88% | ₹179 Cr | — |
| KRM Ayurveda Limited | ₹556 Cr | 25.9 | — | ₹32 Cr | — |
| Trident Lifeline Limited | ₹501 Cr | 24.8 | — | — | +39.4% |
| Denis Chem Lab Ltd | ₹86 Cr | — | — | ₹44 Cr | -35.2% |
Listed by market capitalisation. Ratios are shown for context only.
Denis Chem Lab Ltd is trading at ₹62.69, with a market capitalisation of ₹86 Cr.
Denis Chem Lab Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).
Denis Chem Lab Ltd is listed on the BSE under the scrip code 537536.
Denis Chem Lab Ltd's share price is down 35.2% over one year and down 14.0% over three months. Its 52-week range is ₹56.10 to ₹94.60.
In Q1 FY27, Denis Chem Lab Ltd reported revenue of ₹44 Cr and net profit of ₹2 Cr, with basic EPS of ₹1.47 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.